A Hebrew University researcher calls for finasteride removal from the market after finding that many may have died by suicide from the hair-loss medication's side effects.

While DTC telehealth companies remove barriers to care for patients, questions remain regarding patient safety and proper education of these products.

This article was reviewed by Knox Beasley, MD Oral vs. Topical Minoxidil: Which Is Better for Hair Loss? Minoxidil is one of the most commonly used ...

If you look for hair loss solutions, you’ll undoubtedly come across caffeine in shampoos and scalp tonics. These products are often marketed as preventing hair loss and promoting hair regrowth — but ...

New Israeli research suggests finasteride, a common baldness drug, poses significant mental health risks, including depression and suicidal thoughts.

Biopharmaceutical company Veradermics announced this week that it has secured financing for the phase three trials it needs to get FDA approval for a drug, currently known as VDPHL01, that would be ...

Backed by GV and Arch Venture Partners, Pelage Pharmaceuticals is advancing a first-of-its-kind topical gel designed to activate dormant hair follicle stem cells.

UCLA scientists developed PP405, a new hair growth drug that reactivates dormant follicles—potentially the most effective baldness treatment yet.

However, a new drug may finally change all that. Veradermics, a Connecticut-based biopharmaceutical company, is developing a new drug specifically for androgenetic alopecia, or pattern hair loss, in ...

1 Department of Urology, Beijing TianTan Hospital, Capital Medical University, Beijing, China 2 Department of Gastroenterology, The People’s Hospital of Jimo District, Qingdao, Shandong, China ...

Researchers from the Schweitzer Biotech Company in Taiwan have created a serum which shows promising results for patients with hair loss after just two months.